RxLaunchOS product direction
Choose a commercialization partner with a process you can defend.
RFP Intelligence is being developed to help pharmaceutical manufacturers define a real decision, build a vendor-neutral request, compare documented evidence, and retain the human decision. It does not select a firm—including UEM.
The manufacturer-side difference
The process should work the same way whether UEM is a bidder or not.
Vendor selection often begins with a familiar template and ends with proposals that are hard to compare. Important questions change too late, evidence is uneven, and the reason for the final choice disappears into a meeting or slide deck.
RxLaunchOS is intended to give the manufacturer a durable, decision-owned record from scope through comparison. UEM can be considered as one qualified partner, but never as the system's decision-maker.
How the product is intended to work
Four steps, one accountable decision trail.
- 01
Frame the decision before the RFP
Clarify what the manufacturer needs to decide: the commercial problem, launch stage, scope, geography, needed capabilities, data and integration needs, timing, constraints, and accountable owner.
- 02
Lock the rules before responses arrive
Build a right-sized request with relevant questions, response format, evidence expectations, pricing structure, demonstration instructions, and a comparison rubric. The criteria should not move to favor the most persuasive response.
- 03
See what the response actually supports
Connect a vendor’s answer, excerpt, artifact, exception, contradiction, or missing proof to the exact question it addresses. A polished proposal is not proof by itself.
- 04
Keep the award decision with the manufacturer
Review the comparison record with its limitations, conflicts, uncertainty, evaluator determinations, and rationale. The named decision owner makes the selection and records why.
What remains with you
A clearer process is not a transfer of authority.
- The scope, requirements, criteria, and commercial terms
- Who can see confidential material and who must recuse
- The evaluators, decision owner, and any override rationale
- The final selection, contract, and accountable launch outcome
What the product will not do
- Recommend or award a firm
- Hide referral economics or give UEM special treatment
- Turn a missing answer into a passing score
- Treat a vendor claim as verified evidence without review
- Replace procurement, legal, compliance, or accountable leadership judgment
Where it can help
A process for the launch decisions that cannot be left to a beauty contest.
- Field commercialization, CSO, or hybrid operating-model partners
- Launch-excellence, strategy, market-access, and evidence specialists
- Commercial-data, CRM, analytics, patient-services, and integration partners
- Distribution, logistics, training, enablement, and other launch-critical capabilities
Current availability
Controlled validation before broad access.
The RFP Intelligence workflow is under controlled validation. It requires an authorized workspace and approved methodology before it can issue, compare, or score an RFP. The public RxLaunchOS demonstration is read-only and does not accept vendor material.
Start with the decision
Bring the partner choice your team needs to make.
UEM can help clarify the decision, current evidence, selection process, and whether a scoped product conversation is appropriate. The manufacturer retains the choice of partner.
Start a conversation